Related Experiment Video
Updated: Jun 4, 2025
10:21
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
377
The Association Between Sarcoidosis and Malignancy: A Comprehensive Population-Based Cohort Study.
Yonatan Shneor Patt1,2, Niv Ben-Shabat1,2, Kassem Sharif1,2,3
1Department of Internal Medicine B, Sheba Medical Center, Tel-Hashomer, Ramat Gan 5262100, Israel.
Journal of Clinical Medicine
|December 17, 2024
Summary
This study found sarcoidosis patients have a higher risk of developing both blood and solid cancers. The increased cancer risk is evident both shortly after and long after a sarcoidosis diagnosis.
Area of Science:
- Oncology
- Immunology
- Epidemiology
Background:
- Sarcoidosis is a multisystem granulomatous disease with unknown associations with cancer.
- Previous research has not clarified the temporal relationship or specific cancer links with sarcoidosis.
Purpose of the Study:
- To investigate the association between sarcoidosis and malignancy.
- To analyze varying time intervals between sarcoidosis and cancer diagnoses to understand their relationship.
Main Methods:
- Retrospective cohort study of nearly 24,000 sarcoidosis patients and matched controls (2000-2015).
- Comparison of malignancy rates across different timeframes: overall, within one year, and beyond one year of sarcoidosis diagnosis.
- Logistic regression models used to estimate odds ratios, adjusting for sociodemographic and clinical variables.
Main Results:
- Sarcoidosis patients showed a significantly higher prevalence of malignancies (19.5%) versus controls (13.6%).
- Significant associations were found for both hematologic (OR: 2.94) and solid malignancies (OR: 1.41).
- Strongest association observed with lymphoma (OR: 14.88), especially within one year of sarcoidosis diagnosis; elevated odds persisted long-term for other cancers.
Conclusions:
- Confirms a significant short-term and long-term association between sarcoidosis and both hematologic and solid malignancies.
- Highlights the need for increased clinical vigilance in sarcoidosis patients regarding cancer risk.
- Suggests further research into shared genetic and environmental mechanisms underlying the sarcoidosis-cancer relationship.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
4.9K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
4.9K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
02:59Cancer Prevention
6.0K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.0K
01:25Statistical Methods for Analyzing Epidemiological Data
299
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
299
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328